Invalidation of Microsomal Prostaglandin E Synthase-1 (mPGES-1) Reduces Diet-Induced Low-Grade Inflammation and Adiposity-Reference-Cited by-同舟云学术

Invalidation of Microsomal Prostaglandin E Synthase-1 (mPGES-1) Reduces Diet-Induced Low-Grade Inflammation and Adiposity

Published:2018-10-02 Issue: Volume:9 Page:
ISSN:1664-042X
Container-title:Frontiers in Physiology
language:
Short-container-title:Front. Physiol.

Author:

Pierre Clément,Guillebaud Florent,Airault Coraline,Baril Nathalie,Barbouche Rym,Save Etienne,Gaigé Stéphanie,Bariohay Bruno,Dallaporta Michel,Troadec Jean-Denis

Funder

Aix-Marseille Université

Centre National de la Recherche Scientifique

Publisher

Frontiers Media SA

Subject

Physiology (medical),Physiology

Reference60 articles.

1. White adipose tissue browning: a double-edged sword.;Abdullahi;Trends Endocrinol. Metab.,2016

2. Macrophage recruitment in obese adipose tissue.;Bai;Obes. Rev.,2015

3. An update in the management of obesity: the weight of CNS targets.;Bariohay;Recent Pat. CNS Drug Discov.,2011

4. Amelioration of obesity-associated inflammation and insulin resistance in c57bl/6 mice via macrophage polarization by fish oil supplementation.;Bashir;J. Nutr. Biochem.,2016

5. The PGE2 EP3 receptor regulates diet-induced adiposity in male mice.;Ceddia;Endocrinology,2016

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microsomal Prostaglandin E Synthase-1 and -2: Emerging Targets in Non-Alcoholic Fatty Liver Disease;International Journal of Molecular Sciences;2023-02-03

2. The biological actions of prostanoids in adipose tissue in physiological and pathophysiological conditions;Prostaglandins, Leukotrienes and Essential Fatty Acids;2022-11

3. Prostaglandin PGE2 Receptor EP4 Regulates Microglial Phagocytosis and Increases Susceptibility to Diet-Induced Obesity;Diabetes;2022-11-01

4. Cyclooxygenase-2 in adipose tissue macrophages limits adipose tissue dysfunction in obese mice;Journal of Clinical Investigation;2022-05-02

5. Microsomal prostaglandin E synthase‐1 is involved in the metabolic and cardiovascular alterations associated with obesity;British Journal of Pharmacology;2022-02-05